How does SARS-CoV-2 cause COVID-19?

NJ Matheson, PJ Lehner - Science, 2020 - science.org
… in the lung injury caused by SARS-CoV and SARS-CoV-2, and high plasma angiotensin
II is reported in patients with COVID-19. However, MERS-CoV causes a similar lung disease …

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis

S Talic, S Shah, H Wild, D Gasevic, A Maharaj, Z Ademi… - bmj, 2021 - bmj.com
… are associated with reductions in the incidence covid-19. Public health efforts to implement
public … the effectiveness of public health measures in the context of covid-19 vaccination. …

COVİD-19 (SARS Cov-2) Tedavisi

A Şener - Journal of Biotechnology and Strategic Health …, 2020 - dergipark.org.tr
COVİD 19 tedav s nde kullanılan laç ve komb nasyonlarının çeş tl l ğ neden yle gerek
ülkem … veya nhalasyon le uygulanması MERS CoV ve COVİD 19 ç n uygulamaları vardır9. …

[HTML][HTML] Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals

L Ni, F Ye, ML Cheng, Y Feng, YQ Deng, H Zhao… - Immunity, 2020 - cell.com
… responses to SARS-CoV-2 infection. Here, we collected blood from COVID-19 patients
who have recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-…

The COVID-19 pandemic

M Ciotti, M Ciccozzi, A Terrinoni, WC Jiang… - Critical reviews in …, 2020 - Taylor & Francis
… of deaths caused by coronavirus disease (COVID-19) led … SARS-CoV-2 and its ability to
infect human cells, and safety issues. Then we focus on the available therapies to fight COVID-19

[HTML][HTML] COVID-19: immunopathogenesis and Immunotherapeutics

L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
… well as potential therapeutic targets for COVID-19. In this review, we summarize the
immune characteristics of COVID-19 and discuss the potential mechanisms of SARS-CoV-2-induced …

[HTML][HTML] SARS-CoV-2: a storm is raging

SF Pedersen, YC Ho - The Journal of clinical investigation, 2020 - Am Soc Clin Investig
… This study demonstrates that cytokine storm is associated with COVID-19 disease severity,
likely through increased pulmonary pathology, T cell depletion, and CD4 + T cell dysfunction. …

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status

TM Abd El-Aziz, JD Stockand - Infection, Genetics and evolution, 2020 - Elsevier
… Currently, no specific medication is recommended to treat COVID-19 patients. However…
coronavirus. In the current review, we summarize the existing state of knowledge about COVID-19

Coronaviruses and SARS-CoV-2: a brief overview

S Ludwig, A Zarbock - Anesthesia & Analgesia, 2020 - journals.lww.com
coronavirus 2 (SARS-CoV-2) and defined as the causal agent of coronavirus disease 2019
(COVID-19… , the virus has spread globally, and COVID-19 was declared a pandemic by the …

Immune response to SARSCoV‐2 and mechanisms of immunopathological changes in COVID19

AK Azkur, M Akdis, D Azkur, M Sokolowska… - Allergy, 2020 - Wiley Online Library
… disease caused by SARS-CoV-2 is named coronavirus disease 2019 (COVID-19). …
SARS-CoV-2 spike binding and subsequent infection may also have beneficial effects on COVID-19